Stockscreener 앱 받기
63.88
0.09%
0.055
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
Encompass Health Expands Rehab Footprint With New Maine Hospital - Zacks Investment Research
GeneDx Holdings (NasdaqGS:WGS) Stock Forecast & Analyst Predictions - Simply Wall Street
GeneDx CEO Katherine Stueland sells $1.03m in stock - Investing.com
GeneDx Director Thomas Fuchs Reports RSU Conversion to 1,146 Shares - Kalkine Media
GeneDx (WGS) CEO sells 10,501 shares to cover taxes - Stock Titan
Tax-driven stock sale by GeneDx (WGS) CFO after RSU vesting - Stock Titan
GeneDx Holdings (WGS) director receives 1,146 shares at no cash cost - Stock Titan
GeneDx (WGS) CEO sells shares in tax-withholding trade - Stock Titan
GeneDx (WGS) CFO sells stock for taxes, holds 41,476 shares - Stock Titan
WGS: GeneDx Holdings Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C - Yahoo Finance
GeneDx at Wells Fargo healthcare conference: growth and collections in focus - Investing.com Canada
GeneDx at Wells Fargo healthcare conference: growth and collections in focus - Investing.com UK
GeneDx Holdings CFO Kevin Feeley Executes 717 Shares at $0 and Sells at $83.84 on Sept. 1, 2026 - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out - ACCESS Newswire
GeneDx Holdings (WGS) CFO sells shares in tax-cover trade - Stock Titan
Insider at GeneDx (NASDAQ: WGS) lines up new stock sale after June tax trades - Stock Titan
Planned $1.2M insider sale at GeneDx (NASDAQ: WGS) tied to 2026 RSU vesting - Stock Titan
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree - marketscreener.com
WGS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against GeneDx Holdings Corp - Eastern Progress
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics AcquisitionHBSS - Eastern Progress
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Eastern Progress
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
GeneDx Holdings (WGS) Study Data Puts Its Fair Value Debate Back In Focus - Sahm
A GeneDx study found genetic diagnoses in 63% of children with faltering growth - Stock Titan
A Look at GeneDx Holdings Corp (WGS) After 5.5% Gain -- GF Value $73.66 vs Price $87.06 - GuruFocus
GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE - MarketBeat
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Cor - The National Law Review
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-08-18 | GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:WGS | Press Release - Stockhouse
GeneDx: Why I Think The Worst Is Behind The Business (NASDAQ:WGS) - Seeking Alpha
WGS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Inv - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GeneDx Holdings (WGS) Slips 1.35% to $78.08, Holds Midpoint of Trading RangeCall Flow Alert - Vinanet
GeneDx Holdings (WGS) Slips 1.35% as Shares Hold Between Key Support and ResistanceDelta Hedging - Vinanet
GeneDx Holdings (WGS), Why Is This Fresh Development Drawing Attention? - Sahm
Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily
The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire
Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
0.47%
16.22%
자본화:
|
볼륨(24시간):